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Postnatal overconsumption of fat is believed to increase the susceptibility to metabolic dis-
ease in the later life. Here we examined whether prior exposure to high fat (HF) in the adult-
hood may also accelerate the development of metabolic disorders in mice. Adult mice (12
weeks) were pre-exposed to two episodes of an HF diet each for 2 weeks followed by 2
weeks of washout with a low-fat diet. The mice were then fed the same HF diet for 6 weeks.
Unexpectedly, prior exposures to HF diet significantly alleviated body weight gain, visceral
adiposity and glucose/insulin intolerance during the period of last HF feeding. These pro-
tective effects were evident without changing calorie intake and were specific for HF, but
not high fructose (HFru) diet. Following the HF prior exposures was increases in plasma
fibroblast growth factor 21 (FGF21), the expressions of phospho-AMP-activated protein ki-
nase (pAMPK), mitochondrial complex II and the expression of uncoupling protein (UCP) 3
in muscle and UCP1 and Sirtuin 1 (SIRT1) in adipose tissue. However, in the liver there was
no significant change in pAMPK, SIRT1 expression or the capacity of glucose production.
These findings indicated that, instead of exacerbating metabolic conditions, prior exposures
to HF diet lead to the preconditioning against subsequent overload of HF, possibly involving
FGF21-associated enhancement of markers for metabolic capacity in muscle and adipose
tissue. This paradoxical phenomenon may offer a unique paradigm to identify factors and
explore dietary ingredients with beneficial effects for the control of the metabolic syndrome
in humans.
Introduction
Central obesity and insulin resistance are fundamental to the pathogenesis of the metabolic syndrome
[1,2]. Increased consumption of high-calorie diets and decreased energy expenditure (such as in a seden-
tary lifestyle) are major risk factors of obesity [1,2]. One of the most important dietary compositions lead-
ing to obesity and insulin resistance is the high fat (HF) content in diet, particularly the lard-basedHF diet
[3,4]. However, it remains unclear that whether prior exposure to HF diets in adulthood has long-term
metabolic effects after the cessation of the HF feeding.
There is emerging evidence to suggest that various environmental factors may have long-term im-
pacts on the metabolic syndrome. A well-known example is the long-term benefits of an inten-
sive glycaemic control for diabetic patients in a 10-year post-trial follow-up of the United King-
dom Prospective Diabetes Study [5,6]. In addition, caloric restriction for a period of time in adult-
hood has been shown to delay the aging and extend the lifespan in various animal models [7,8].
In humans, it has been reported that calorie restriction can induce long-term weight loss [9].
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Figure 1. Schematic illustration of study design
(A) Male C57BL/6J mice at age of 12 weeks were assigned to different dietary regiments to examine the legacy effects of precondi-
tioning on subsequent exposure to the HF diet. Preconditioning was introduced twice with HF diet, each followed a washout period
by a CH diet. Abbreviations: CH-Con, normal CH control mice (without preconditioning); naı¨ve-HF, HF-fed mice without precondi-
tioning; Precon-CH, CH-fed mice after HF preconditioning; Precon-HF, HF-fed mice after preconditioning with the same HF diet.
(B) In a separate experiment, mice were fed either a HFru or CH diet with the same feeding episodes of the HF-preconditioning
experiment to compare the effects of HFru prior exposures on subsequent exposure to the same HFru. Abbreviations: Naı¨ve-HFru,
HFru-fed mice without preconditioning; Precon-CH, CH-fed mice after HFru preconditioning, Precon-HFru: HFru-fed mice after
preconditioning with the same HFru diet.
Based on these reports, it appears to be reasonable to speculate that HF feeding diet may have certain long-lasting
effects on whole-body metabolism beyond the feeding period.
Indeed, overfeeding of postnatal rats can increase the risk of developing obesity and fatty liver disease in adulthood
[10–12]. In analogue to this, obese children are more likely to develop obesity and associated metabolic disorders in
their adulthood [13]. Therefore, we hypothesise that prior feeding with an HF diet in adulthood may exacerbate the
metabolic syndrome when challenged with subsequent feeding of the HF diet. To test this hypothesis, the present
study fed adult mice two episodes of HF diet and then re-fed the animals the same HF diet after the initial metabolic
disorders was washed out with a chow (CH) diet. The metabolic response to the subsequent HF feeding was assessed
by examining the adiposity and pre-diabetic indicators compared with those of the HF-fed mice without any prior
exposure.
Materials and methods
Animal study
Male C57BL/6J mice (10 weeks old) were purchased from Animal Resources Centre (Perth, Australia) and housed at
22 +− 1◦C on a 12-h light/dark cycle with free access to water and food. After acclimatisation for 2 weeks, mice were
assigned ad libitum to four dietary regimens to examine the effects of HF prior exposures on subsequent exposure
to the HF diet as illustrated in Figure 1A. The macronutrients of CH diet were composed of (in calories) 70% car-
bohydrates, 10% fat, 20% protein (Specialty Feeds, Australia). The HF diet consisted of 45% calories from fat (lard),
20% calories from protein and 35% calories from carbohydrate supplemented with 0.2% cholesterol [14]. In a sepa-
rate experiment, mice were preconditioned with a high fructose (HFru) diet in the identical protocol to compare the
effects of HFru prior exposures on subsequent exposure to the same HFru (Figure 1B). The calories of the HFru diet
were made of 35% fructose, 35% starch, 10% fat and 20% protein [15,16]. Body weight (BW) and food intake were
monitored three times a week. All experiments were approved by the Animal Ethics Committee of the Royal Mel-
bourne Institute of Technology University (Project #1414) in accordance with the guidelines of the National Health
and Medical Research Council of Australia.
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Assessment of metabolic response
Themetabolic response of the preconditioning was assessed during the final six weeks of HF feeding. For glucose tol-
erance test (GTT), animals were fasted for 5 h and glucose (2.0 g/kg BW) was administrated to animals by intraperi-
toneal (ip) injection. Blood glucose levels were measured at 0, 15, 30, 60 and 90 min using a glucometer (Accu-Chek,
Roche) whereas blood insulin levels were sampled at 0, 15, 60 and 90min from the tail vein into heparin-coated capil-
lary tubes (SteriHealth, #I-10086). The whole-body insulin sensitivity of mice was measured at week 11 by an insulin
tolerance test (ITT) [17]. After 5 h of fasting, insulin (100 IU/ml, Novo Nordisk Novorapid Penfill) was diluted to 0.2
IU/ml with saline and injected intraperitoneally into the mice to reach a final dose of 0.75 IU/kg BW. Subsequently,
blood glucose levels were measured at 0, 20, 40, 60 and 80 min using a glucometer. The capacity of hepatic glucose
production was measured by ip pyruvate tolerance tests (ipPTT) [17,18]. Pyruvate (Sigma–Aldrich, #2256) was pre-
pared in 1× PBS buffer. Pyruvate (2.0 g/kg BW) was administered to animals by ip injection after overnight fasting.
Blood glucose levels were measured at 0, 15, 30, 60 and 90 min using a glucometer. At the end of the study, mice
were killed by cervical dislocation after removing the food for 5–7 h. Plasma samples were collected from the tail tip
before the killing of mice and stored at −80◦C. Epididymal fat mass was weighed using an analytical balance. Liver
and quadriceps muscle were free-clamped and stored at −80◦C for subsequent analysis.
Plasma fibroblast growth factor 21 (FGF21) levels were measured using an ELISA kit from Hong Kong Univer-
sity Antibody and Immunoassay Services (#32180) following the manufacturer’s instructions. The effects on hepatic
steatosis were assessed by measuring the triglyceride (TG) content in the liver. Liver TGs were extracted from the
freeze-clamped liver tissue by the method of Bligh and Dyer [19]. Briefly, tissue samples were homogenised in a mix-
ture of chloroform and methanol (2:1) using a glass homogeniser and placed on a shaker overnight. NaCl (0.6%) was
added to extract the aqueous phase. The mixture was centrifuged at 1000×g for 10 min and the lower organic phase
was transferred to a new tube. The extract was then dried and redissolved in ethanol prior to the measurement of TG
concentrations using a TG GPO-PAP reagent (Roche Diagnostics, #11730711216, Australia) [20].
Measurement of mtDNA content
Total DNA, including mitochondrial DNA (mtDNA) and genomic DNA, was isolated from tissues using a DNA
isolation kit from Invitrogen (#K1820-02). The DNA extract was quantitated and diluted to 2 ng/μl as the tem-
plate for PCRs. Monocarboxylate transporter 1 (MCT-1) and NADH-ubiquinone oxidoreductase chain 5 (ND-5)
were used as a marker of genomic DNA and mtDNA, respectively. The sequences of primers were: MCT-1 for-
ward 5′-TAGCTGGATCCCTGATGCGA-3′;MCT-1 reverse 5′-GCATCAGACTTCCCAGCTTCC-3′; ND-5 forward
5′-GCAGCCACAGGAAAATCCG-3′; ND-5 reverse 5′-GTAGGGCAGAGACGGGAGTTG-3′.
Measurement of citrate synthase and β-hydroxyacyl-CoA dehydrogenase
activity
Citrate synthase (CiS) and β-hydroxyacyl-CoA dehydrogenase (β-HAD) activities were measured as previously de-
scribed [16]. Frozen samples were homogenised in a buffer (pH 7.4) containing 175 mmol/l KCl and 2 mmol/l
EDTA. For CiS activity, tissue homogenates were mixed with a working solution containing 450 μM acetyl-CoA
(Sigma–Aldrich, #A2056) and 0.1 mM 5,5’-dithiobis(2-nitrobenzoic acid) (DTNB, Sigma–Aldrich, #D218200), and
absorbance was measured at 405 nm as blank values. Oxaloacetic acid (Sigma–Aldrich, #O4126, final concentration
1 mM) was then added to the assay system to initiate the reaction. The enzyme activity was calculated based on the
slope of the absorbance curve. For β-HAD activity, tissue homogenates were mixed with a working solution contain-
ing 0.2mMNADH(Sigma–Aldrich, #N4505) and absorbance at 340 nmwasmeasured as the blank. Acetoacetyl-CoA
(Sigma–Aldrich, #A1625, final concentration 0.1mM)was then added to the assay system to initiate the reaction. The
enzyme activity was calculated based on the slope of the absorbance curve and the extinction coefficient of NADH
(6.22 μmol−1.cm−1).
Western blotting
Western blotting was performed as described previously [21]. Proteins prepared in Laemmli buffer were separated by
SDS/PAGE, then transferred to PVDFmembranes (Bio-Rad,U.S.A.) and blocked in 3%BSA.Membraneswere probed
with the following primary antibodies. Anti- total- and phospho- AMP-activated protein kinase (AMPK), anti-sirtuin
1 (SIRT1), anti- total- and phospho- acetyl-CoA carboxylase (ACC), anti-glyceraldehyde 3-phosphate dehydrogenase
(GADPH) and anti-tubulin antibodies were purchased from Cell Signaling (U.S.A.). Anti-mitochondrial respiratory
complexes and anti-PGC1α antibodies were obtained from Abcam (U.K.) and Merck Millipore (AU), respectively.
Anti-uncoupling protein (UCP) 1 and anti-UCP3 antibodies were purchased from Santa Cruz Biotechnology (U.S.A.)
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and ThermoFisher Scientific (U.S.A.), respectively.Western blot membranes were incubated with corresponding sec-
ondary antibodies from Santa Cruz Biotechnology (U.S.A.) that were conjugated to horseradish peroxidase (HRP)
and developed using ECL HRP substrate from PerkinElmer (U.S.A.). Images of the membranes were taken with the
ChemiDoc system and densitometry analysis was performed using Image Lab software 5.0 (Bio-Rad Laboratories,
U.S.A.).
Quantitative real-time PCR
RNAwas extracted using TRIzol reagent (Invitrogen, #15596026) and genomicDNAwas digested using amplification
grade DNase (Invitrogen, #18068-015, Australia). RNA extract was reverse-transcribed using a High Capacity cDNA
Reverse Transcription kit (Applied Biosystems, #4368814, Australia) according to the manufacturer’s instructions.
Primers (GeneWorks, Australia) and SYBR green supermix (Bio-Rad, #170-8880, U.S.A.) were used for quantitative
real-time PCR using QIAGEN Rotor-Gene Q PCR system (Germany). 18s was used as the normalising control gene
and results were analysed by the Ct method. Sequences of the primers were: PGC1α AAACTTGCTAGCGGTC-
CTCA (forward) and TGGCTGGTGCCAGTAAGAG (reverse); UCP3 TGTCAACCAACTTCTCTAGGATAAGG
(forward) andCACTGTTGTCTCTGCTGCTTCTG (reverse); and 18SCGCCGCTAGAGGTGAAATTCT (forward)
and CGAACCTCCGACTTTCGTTCT (reverse).
Statistical analyses
Datawere expressed asmeans+− S.E.M. The individual results were screened for their distribution patterns prior to the
statistical tests. A Student’s t test was performed for the comparison of normal distributed data. Data of FGF21 did not
follow a normal distribution and thus statistical comparisons were made using a nonparametric test for independent
samples (SPSS statistics 23). Differences at P<0.05 were considered statistically significant.
Results
Effects of HF prior exposures on HF-induced BW gain and adiposity
During the first episode of HF feeding, mice fed with the HF diet gained twice as much BW as mice fed the CH diet
(Figure 2A). When these mice were subsequently fed the CH diet as a washout, their BW reduced, and their BW gain
was not different from the CHmice at the end of the 2 weeks of CH feeding. Similarly, as soon as the second episode
of HF diet started, the BW of the mice began to increase, and their BW gain was twice that of their CH counterparts
at the end of the second exposure. Within 2 weeks after they were switched back to the CH diet again, the body mass
of the mice pre-exposed to HF (preconditioned) returned to the level of the CH mice (Figure 2B).
After the washout with CH, mice were fed either the HF diet again or kept on the CH diet to investigate the legacy
effect in response to a subsequent exposure to the HF diet. After switching back to the CH diet, the BW gain of
preconditioned mice kept on CH diet (Precon-CH) was similar to that of the control CH group (CH-Con) (Figure
2A). Interestingly, the preconditioned mice gained less BW during the subsequent feeding with the same HF diet
(Precon-HF) than the mice exposed to the HF diet for the first time (Na¨ıve-HF) despite similar food intake (Figure
2A,C). At the end of the experiment, the BW gain and the fat pad mass of the Precon-HF group was 22 +− 9% less
and 26 +− 9% less respectively, compared with the Na¨ıve-HF group (both P<0.05, Figure 2D,E). Together, these data
indicate that the HF-preconditioning ameliorated the adiposity induced by subsequent exposure to the sameHF diet,
suggesting an induction of a legacy effect.
Effects of HF prior exposures on HF-induced glucose and insulin
intolerances
Insulin resistance is generally associated with obesity, and it is a major characteristic of type 2 diabetes. ipGTT and
ipITT were performed to assess the legacy effect of preconditioning on whole-body glucose and insulin tolerance of
mice. Compared with the CH-Con group, the Precon-CH had no changes in response to the glucose injection during
ipGTT, as indicated by overlapping blood glucose curves (hence similar incremental area under the curve (iAUC))
(Figure 3A). However, when na¨ıve or preconditioned mice were challenged with the HF diet, blood glucose levels of
the Precon-HF mice were lower (27 +− 7%, P<0.05) at 60 min of the GTT and their iAUC values were less (23 +− 8%,
P<0.05) than the Na¨ıve-HF group. This indicates that preconditioning ameliorated HF-induced glucose intolerance.
To further assess the response of blood glucose levels to insulin stimulation, an ipITT was performed (Figure 3B).
Again, the Precon-CH group showed a similar reduction in glucose levels and AUC in response to insulin injection
compared with the CH-Con group. Although not statistically significant, blood glucose levels tended to be more
reduced in the Precon-HF group compared with the Na¨ıve-HF group at 20, 40, 60 and 80 min during the ipITT.
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Figure 2. Effects of HF prior exposures on HF-induced BW gain and adiposity
The effects were assessed during the final 6 weeks of HF feeding after 2 weeks of washout with CH diet following HF precondi-
tioning. (A) BW gain over time from the baseline during the assessment period. (B) BW at the baseline before the final period of HF
feeding. (C) Cumulative calorie intake during the first 8 days of metabolic assessment period. (D) BW gain from the baseline and
(E) the weight of epididymal fat mass at the end of study. **P<0.01 compared with CH-Con; †P<0.05, ††P<0.01 compared with
indicated group (n=8–10/group).
Furthermore, the AUC of the Precon-HF group was 13+− 5% less than the Na¨ıve-HF (P<0.05). These results indicate
that HF-preconditioning has protective effects against the HF-induced glucose intolerance and improves whole-body
insulin sensitivity of HF mice.
Effects of HFru prior exposures on HFru-induced adiposity
Overconsumption of sucrose is known to cause the human metabolic syndrome largely from the derived fructose
[22–25] and similar metabolic characteristics well resemble in HFru rodents including mice [16,26,27]. Thus, in a
separate experiment, we fed mice with a HFru diet [16] under identical protocol for the HF-preconditioning ex-
periment to examine whether a legacy effect may also occur in HFru-preconditioned group. Mice in four different
groups (CH-Con, Precon-CH, Naı¨ve-HFru, Precon-HFru) showed similar BW gain over the whole experiment pe-
riod (Figure 4A). At the end of the experiment, there was no significance of epidydimal (Epi) fat weight between
Na¨ıve-HFru group and Precon-HFru group (0.51 +− 0.03 compared with 0.48 +− 0.05, P>0.5, Figure 4B). In addi-
tion, blood glucose levels were similar in four groups during ipGTT and ipITT (Figure 4C,D). These results indicate
that these beneficial legacy effects are specific to HF diet, but not to HFru diet, suggesting a possible involvement of
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 3. Effects of HF prior exposures on HF-induced glucose and insulin intolerances
Glucose tolerance was performed by an ip injection of glucose at 2.0 glucose/kg BW (ipGTT) after week 2 of the final HF feeding
(week 10). ITT was performed in following week (week 11) at a dose of 0.75 IU insulin/kg BW (ipITT). (A) Blood glucose levels during
the ipGTT and its iAUC from 0–90 min (iAUC); (B) Blood glucose levels during the ipITT and its area under the curve from 0–90 min
(AUC). **P<0.01 compared with CH-Con; †P<0.05 compared with indicated group (n=7–9/group).
HF-derived factors. We then examined the effect of HF-preconditioning on liver, muscle and adipose tissues, the key
organs for energy metabolism and glucose homoeostasis.
Effects of HF prior exposures in liver
As one of the major tissues in the regulation of glucose, the liver plays an important role in maintaining glucose
homoeostasis via gluconeogenesis from substratemetabolites such as pyruvate and lactate. The PTTmeasures hepatic
glucose production from the injected pyruvate through gluconeogenesis. It can be used to determine whether there is
an increase in the capacity of hepatic glucose production. As shown in Figure 5A, the glucose levels and AUC during
the PTT in preconditioned mice were similar to those in na¨ıve mice, either between the Precon-CH and CH-Con
group or between Precon-HF andNaı¨ve-HF group. This suggests that HF-preconditioning did not significantly affect
the capacity for glucose production in the liver.
Next, the effect of HF-preconditioning on hepatic steatosis was assessed by measuring TG content in the liver. As
shown in Figure 5B, when mice were fed either CH or HF, preconditioning did not change the TG content in the
liver compared with mice that had not been preconditioned. This suggests that protection against obesity through
HF-preconditioning was not related to changes in hepatic steatosis.
AMPK plays a pivotal role in the suppression of glucose production and promotion of fatty acid (FA) oxidation
and mitochondrial biogenesis in the liver [28,29]. SIRT1 is reported to promote FA oxidation through the activation
of PPARα in the liver [30] and regulate the activity of AMPK [31]. However, consistent with the results of ipPTT and
TG content in the liver, no apparent change was observed on the activation of AMPK and its downstream target, ACC
(Figure 5C). Again, no apparent change of the protein level of SIRT1 was observed by HF-preconditioning (Figure
5C).
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Figure 4. Effects of HFru prior exposures on HFru-induced adiposity
The effects were assessed during the final 6 weeks of HFru feeding after 2 weeks of washout with CH diet following HFru precon-
ditioning. (A) BW gain over time from the baseline during the assessment period. (B) The weight of epididymal fat mass at the end
of study. Glucose tolerance was performed by an ip injection of glucose at 2.0 glucose/kg BW (ipGTT) after week 2 of the final HFru
feeding (week 10). ITT was performed in following week (week 11) at a dose of 0.75 IU insulin/kg BW (ipITT). (C) Blood glucose
levels during the ipGTT and its iAUC from 0–90 min (iAUC). (D) Blood glucose levels during the ipITT and its area under the curve
from 0–90 min (AUC). ** P<0.01 compared with CH-Con. Abbreviation: n.s., not statistically significant (n=6–9/group).
Effects of HF prior exposures in muscle
Skeletal muscle is a major contributor to the resting energy expenditure mainly through mitochondrial oxidation
of energy-rich substrates such as FAs. FA oxidation has also been linked to the development of insulin resistance in
this tissue [32,33]. The capacity of mitochondrial oxidative phosphorylation was examined to evaluate the effects of
preconditioning on muscle using the samples collected at the end of the study. Although mitochondrial complex II
in the Precon-CH group increased by 38+− 13% compared with the CH group (P<0.05), complexes I and V were not
affected by preconditioning (Figure 6A). Meanwhile, β-HAD and CiS are two mitochondrial enzymes involved in
mitochondrial FA oxidation and their activities are often used as indicators of mitochondrial function [16,34]. The
results showed that their activities were not changed by preconditioning (Figure 6B).
Further analyses were conducted with muscle samples by measuring relevant transcription factors involved in
the regulation of mitochondrial biogenesis, including mRNA expressions of PGC1α and UCP3 together with
pAMPK/total AMPK protein levels. There was a two-fold increase in AMPK phosphorylation in Precon-CH mice
(P<0.05 compared with CH), but no apparent change in Precon-HFmice (P>0.1 compared with Na¨ıve-HF) (Figure
6A). No significant change in PGC1α mRNA expression was observed between na¨ıve and preconditioning groups
(Figure 6C). However, the mRNA expression of this protein was decreased by 50+− 12% in Precon-HF group than the
Na¨ıve-HF group (P<0.05). The Precon-HF group showed a significant increase in mRNA expression level of UCP3
than the na¨ıve-HF group (P<0.05, Figure 6C). A similar trend was observed in the mRNA expression of nuclear res-
piratory factor-1 (NRF1) (Figure 6D). As no consistent effect of preconditioning on the regulation of mitochondrial
biogenesis was observed, total mtDNA content wasmeasured to investigate whether the number ofmitochondria was
affected by preconditioning. The results showed that preconditioning did not affect the mtDNA content in muscle
(Figure 6E).
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Figure 5. Effects of HF prior exposures in liver
The effects of preconditioning in liver were assessed by PTT and examination of liver tissue. (A) Blood glucose levels during the
ipPTT (2.0 g pyruvate/kg BW by an ip injection) assessed after 4 weeks of the final HF feeding (week 12) and blood glucose AUC
(n=6–9/group). (B,C) Liver samples were freeze-clamped at the end of the study (week 14) for the following measurements. (B) TG
content; (C) protein levels of pAMPK, tAMPK, pACC, tACC, and SIRT1 were determined by Western blotting and normalised by
GAPDH (n=6–7/group). *P<0.05, **P<0.01 compared with CH-Con. Abbreviation: n.s., not statistically significant.
Effects of HF prior exposures on plasma FGF21 and metabolic capacity in
adipose tissue
FGF21, an emerging regulator of energy expenditure, has been shown to increase the energy consumption through
multiple mechanisms including the ‘browning’ in white adipose tissue (WAT), which is partly through increasing
PGC1α protein content [35]. An elevation in circulating FGF21 was observed in Precon-CH group compared with
CH-Con group (P<0.01) and a significant increase in Precon-HF group compared with Naı¨ve-HF (P<0.05) (Figure
7A), suggesting the preconditioning of HF diet increased FGF21 level in the blood. In addition, increased expression
of UCP1 is a hallmark of ‘browning’. While no significant increase in the protein level of UCP1 was observed in
8 c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
Bioscience Reports (2018) 38 BSR20181873
https://doi.org/10.1042/BSR20181873
Figure 6. Effects of HF prior exposures in muscle
Quadriceps muscle was collected from the mice at the end of the study (week 14) for the following measurements. (A) Protein
levels of AMPK and mitochondrial complex measured by Western blotting and normalised by GAPDH; (B) β-HAD activity was
measured by the disappearance rate of NADH, and CiS activity (CiS) was detected by detecting the rate of the CoA-SH production
using DTNB. (C) Levels of mRNA expression of PGC1α and UCP3 and (D) nuclear respiratory factor-1 (NRF1) were quantified by
qRT-PCR. (E) mtDNA content was measured by quantificative PCR using MCT-1 (genomic DNA marker) as a control gene. †P<0.05
compared with indicated group (n=8–10/group).
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 7. Effects of HF prior exposures on plasma FGF21 and metabolic capacity in adipose tissue
Epididymal fat was collected from the mice at the end of the study (week 14) for the following measurements. (A) Plasma levels of
FGF21 were measured by ELISA at the end of the study. (B–D) UCP1, AMPK, PGC1α and SIRT1 in epididymal adipose tissue mea-
sured by Western blotting at the end of the study. **P<0.01 compared with CH-Con;†P<0.05, ††P<0.01 compared with indicated
group (n=6–10/group).
the Precon-CH group, there was a 54 +− 20% increase in the Precon-HF group compared with the Na¨ıve-HFC group
(P<0.05, Figure 7B). Interestingly, we observed an increase in pAMPK in Precon-CH group comparedwith CH-Con.
However, when we challenge mice with HF diet again (Precon-HF), this increase disappeared (Figure 7C). PGC1α
is a key transcription factor that regulates gene expression involved in the ‘browning’ [36]. However, there was no
apparent change in themRNA expression levels of PGC1αwith preconditioning regardless the subsequent CH or HF
challenge (Figure 7D). It has been suggested that ‘browning’ of WAT can be regulated by SIRT1 [37]. A significant
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increase in SIRT1 protein levels was observed in Precon-HF compared with the Na¨ıve-HF group and a similar trend
was observed in Precon-CH group compared with the CH-Con group (Figure 7D).
Discussion
The present study investigated whether prior exposures to HF diet in the adulthood may induce long-lasting risk to
the development of the metabolic syndrome. Based on the reported risk of the early life experience like this [10–13],
we had hypothesised that prior feeding with an HF diet would exacerbate the metabolic syndrome in the subsequent
response to the HF diet. In opposite to our initial hypothesis, the results showed that exposures to HF diet in adult
mice actually blunted the severity of BW gain, central adiposity and glucose intolerance. This finding indicates that
prior HF exposures induce mechanisms of adaptation to resist the metabolic syndrome, conceptually similar to the
preconditioning against ischaemic injury in heart [38]. Because the metabolic syndrome during the prior HF expo-
sures had been washed out, the sustained protective effects can be considered as the legacy effects as described after
certain interventions [5,6]. It is also interesting to note that the observed protection effects only occurred in prior
HF exposures (preconditioning) but not occurred in HFru diet, which induces the metabolic syndrome from hepatic
steatosis by intrinsic lipogenesis [39].
HF feeding in mice can induce obesity and associated metabolic disorders which have been well characterised to
resemble the metabolic syndrome in humans from overconsumption of fat [40–42]. As HF-fed mice can develop
obesity, glucose intolerance and hepatic steatosis within 2 weeks [40,43], the present study set 2 weeks to induce the
full metabolic effects for the two episodes of HF prior exposures (or preconditioning). As expected, the effectiveness
of the HF preconditioning was demonstrated clearly in the present study by an increased BW gain during each period
of the preconditioning. To examine the legacy effects separately from the metabolic syndrome directly produced by
HF preconditioning, the metabolic responses were assessed after 2-week washout by a normal low-fat diet, namely
CH. Indeed, the direct metabolic effects (as indicated by BW gain) of HF diet during the preconditioning period were
reversed to the normal after switching to the CH diet for 2 weeks. Following these prior treatments, the metabolic
responses to theHFdiet during the subsequent period of 6weeks represent the legacy effects in a reasonably long-term
in adult mice.
Unlike the reported detrimental legacy effects of HF diet in parents on the offspring [44] or from prenatal to adult
[45], the present study revealed the protective effect of HF preconditioning (Precon-HF group) in reducing the BW
gain response to subsequent HF feeding compared the mice without HF preconditioning (Naı¨ve-HF group). Consis-
tent with this, visceral fat mass, iAUC during ipGTT and AUC during ipITT in Precon-HF mice were significantly
lower than the Na¨ıve-HF group. These results suggest that the mechanisms involved in the legacy effects of HF pre-
conditioning in the same generation of the adult are different from those underlying legacy effects on the offspring
exposure to HF diet to its parent generation. For example, the legacy effects displayed in the offspring as a result of
HF prior exposure in the parent are believed to result from epigenetic alterations in the reproductive cells [44]. Sim-
ilarly, the impact of perinatal factors to the adulthood is likely to involve the change in organ/tissue development via
altered genetic programming [46]. Because the present studies were conducted in mature adult mice, it is likely that
themechanisms lie in the organs directly responsible for the homoeostasis of energy balance and glucosemetabolism.
Since the observed protective effects occurred without a significant change in caloric intake, mechanisms under-
lying the protective effects of preconditioning on obesity and glucose metabolism, relevant parameters indicative
of changes in metabolism in the liver, muscle and adipose tissue (major peripheral tissues responsible for energy
metabolism and glucose homoeostasis) were examined.
In the liver, there was no improvement in either capacity of glucose production (indicated by an unchanged re-
sponse to a PTT) or hepatic steatosis (indicated by unchanged TG content) between Precon-HF group and Naı¨ve-HF
group. In addition, the activities of AMPK and SIRT1 did not show apparent changes. These results might suggest
that the liver does not play a significant role in mediating the beneficial legacy effects of HF diet. This interpretation
appears to be consistent with the lack of protective effects of preconditioning with HFru diet in the present study
because liver is the primary organ in HFru-induced metabolic syndrome [39].
Next, the markers involved in mitochondrial oxidative phosphorylation and FA metabolism were measured as
an indication of the capacity of energy metabolism in the muscle. The overall mitochondrial content (indicated by
mtDNA content) and activities of enzymes involved in mitochondrial FA oxidation were not affected by precondi-
tioning, despite increases in AMPK activation and mitochondrial complex II in Precon-CH mice. The reason for
this discrepancy is unknown and further studies are needed to determine whether skeletal muscle contributes to the
protective effects of preconditioning.
c© 2018 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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UCP1mediates thermogenesis in adipose tissue and increases energy expenditure. It is expressed in brown adipose
tissue or brown-like adipocyte withinWAT as amarker of browning [1,47,48]. Interestingly, UCP1 protein levels were
increased inWAT of the Precon-HF group. Consistent with the increased UCP1 protein levels, Precon-HF group had
increased levels of circulating FGF21, a key inducer of the ‘browning’ [35], and increased levels of SIRT1 protein
in the WAT. It has been reported that FGF21 and SIRT1 increase the level of PGC1α in WAT respectively, through
post-transcriptional mechanisms [35,37]. Although no apparent change in mRNA expression of PGC1α was ob-
served, further measurement of the protein levels of these two transcription regulators are needed to indicate their
possible involvement in the preconditioning-induced ‘browning’. In addition, it has been suggested that subcutaneous
WAT is more sensitive to FGF21 than the epididymal WAT used in this study [35,49]. This is associated with an in-
crease in UCP1 and SIRT1 levels in WAT as well as an increase in circulating levels of FGF21, which, we speculate,
may be involved in the ‘browning’ ofWAT as a possible mechanism. Because the circulating FGF21 is mainly released
from the liver through the activation of PPARα [50,51], we also speculate that the ‘browning’ in WAT may be indi-
rectly induced by PPARα in the liver. Obviously further research is needed to investigate this possibility by blocking
PPARα such as using PPARα knockout mice or eliminating FGF21 such as using FGF21 knockout mice.
It is also worth pointing out that the present study preconditioned mice with two episodes of HF in an attempt
to boost the metabolic memory of the legacy effects based on the protocols used some immunisations. Future stud-
ies need to investigate whether the observed protective legacy effects may be induced by one single episode of HF
preconditioning and whether the immune system may also be involved. The findings from the present study also
provide a basis for further investigation of various manipulations of dietary regiments such as the legacy effects of
HF preconditioning onHFru-inducedmetabolic syndrome or vice versa. Such studies would shedmore lights on the
mechanism underlying the protective legacy effects observed in the present study.
In summary, the present study shows that HF-preconditioning in adult mice ameliorates the development of obe-
sity and glucose intolerance in response to subsequent feeding of HF diet. The mechanisms of these protective legacy
effects involve the enhancement of metabolic capacity in skeletal muscle andWAT. Similar to the concept of precon-
ditioning protection against ischaemic injury in heart [38], the paradoxical metabolic phenomenon revealed in the
present study may provide novel insight into the identification potential new drug targets for the treatment of obesity
and related metabolic disorders in humans. Additionally, the breakdown products of an HF diet during the intermit-
tent prior exposures may produce by short-chain FAs or ketone bodies which are have been suggested to promote
energy metabolism and induce FGF21 [52]. We speculate that these breakdown products from HF-preconditioning
can also be explored for as possible dietary manipulations to help control the metabolic syndrome in humans.
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